MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neurodegeneration Biomarkers: Correlation between Hippocampal Volume and Cognitive Performance by MoCA Test in Parkinson’s Disease

Y. Matuk Perez, E. Fernandez Calleja, D. Resendiz Gonzalez, JM. Esquivias Farías, S. Alcauter Solórzano, I. Zamorano-Rangel (Queretaro, Mexico)

Meeting: 2025 International Congress

Keywords: Dementia, Magnetic resonance imaging(MRI), Parkinson’s

Category: Parkinson's Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales

Objective: This study aims to examine the relationship between hippocampal volume, assessed through magnetic resonance imaging (MRI), and MoCA test scores in patients diagnosed with Parkinson’s Disease (PD)

Background: Parkinson’s Disease (PD) is a neurodegenerative disorder that affects mobility and cognitive function. Cognitive decline is prevalent among patients, often linked to hippocampal atrophy.(1) Understanding the correlation between hippocampal volume and cognitive performance can provide valuable biomarkers for early diagnosis and management of cognitive deterioration in PD, ultimately improving patient quality of life. (1)

Method: Forty-eight patients diagnosed with PD were recruited from Parkinson Care and MEX-PD. Informed consent was obtained, and participants underwent the MoCA test alongside MRI to evaluate hippocampal volume. A general linear model was used to analyze the correlation between hippocampal volume and MoCA scores, adjusting for age, sex, and years of education

Results: The findings indicated a significant correlation between left hippocampal volume and hippocampal asymmetry with MoCA scores (p<0.05). Greater left hippocampal volume was associated with better cognitive performance. Furthermore, the asymmetry between hippocampal hemispheres impacted cognition, underscoring the importance of considering these measurements in clinical evaluations.

Conclusion: This study supports the notion that left hippocampal volume and hippocampal asymmetry are significant predictors of cognitive performance in patients with PD. Volumetric measurements may serve as useful biomarkers to enhance the diagnosis and management of cognitive decline in this patient population.

References: Tarhan M, Atalay B, Buz Yaşar A, Özdilek FB. Exploring the cognitive assessment potential of MRI-based volumetric hippocampal segmentation in Parkinson’s disease. Brain Behav. 2024 Jul;14(7):e3576. doi: 10.1002/brb3.3576. PMID: 38970157; PMCID: PMC11226409.

To cite this abstract in AMA style:

Y. Matuk Perez, E. Fernandez Calleja, D. Resendiz Gonzalez, JM. Esquivias Farías, S. Alcauter Solórzano, I. Zamorano-Rangel. Neurodegeneration Biomarkers: Correlation between Hippocampal Volume and Cognitive Performance by MoCA Test in Parkinson’s Disease [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/neurodegeneration-biomarkers-correlation-between-hippocampal-volume-and-cognitive-performance-by-moca-test-in-parkinsons-disease/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neurodegeneration-biomarkers-correlation-between-hippocampal-volume-and-cognitive-performance-by-moca-test-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley